Cefazolin sodium and Levaquin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefazolin sodium (cefazolin sodium) and Levaquin (levofloxacin). Common drug interactions include haemangioma of liver among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Cefazolin sodium and Levaquin. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Cefazolin sodium?

Cefazolin sodium has active ingredients of cefazolin sodium. eHealthMe is studying from 3,649 Cefazolin sodium users. Check the latest studies of Cefazolin sodium.

What is Levaquin?

Levaquin has active ingredients of levofloxacin. It is often used in sinusitis. eHealthMe is studying from 56,638 Levaquin users. Check the latest studies of Levaquin.



On Jul, 10, 2026

20 people who take Cefazolin sodium and Levaquin together, and have interactions are studied.

Cefazolin sodium and Levaquin drug interactions.

What are the common drug interactions of Cefazolin Sodium and Levaquin, by gender? *:

female:

  1. Haemangioma of liver (noncancerous, abnormally dense collections of dilated small blood vessels that may occur in liver)
  2. Haemorrhoids (a swollen vein or group of veins in the region of the anus)
  3. Headache (pain in head)
  4. Hypercapnia (too much smoke)
  5. Hyperlipidaemia (presence of excess lipids in the blood)
  6. Hyperosmolar state (life-threatening emergency manifested by marked elevation of blood glucose)
  7. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
  8. Hypertension (high blood pressure)
  9. Hypotension (abnormally low blood pressure)
  10. Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)

male:

  1. Dyspnoea (difficult or laboured respiration)
  2. Anaemia (lack of blood)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Haemorrhage (bleeding)
  5. Rash
  6. Bradycardia (abnormally slow heart action)
  7. Hyperhidrosis (abnormally increased sweating)
  8. Hypotension (abnormally low blood pressure)
  9. Leukocytosis (increased white blood cells)
  10. Nausea (feeling of having an urge to vomit)

What are the common drug interactions of Cefazolin Sodium and Levaquin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Chronic kidney disease
  2. Nephrogenic anaemia (anaemia due to kidney disease)
  3. Renal failure (kidney dysfunction)
  4. Renal tubular acidosis (medical condition that involves an accumulation of acid in the body due to a failure of the kidneys)

40-49:

  1. Diarrhoea
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Chronic kidney disease
  4. Renal injury (kidney injury)
  5. Colitis microscopic (inflammation of colon with diarrhoea and abdominal cramps)

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Blood creatinine increased
  4. Depression
  5. Emotional distress
  6. Humerus fracture (injury to the upper arm bone)
  7. Mobility decreased (ability to move is reduced)
  8. Osteoporosis (bones weak and more likely to break)
  9. Pain
  10. Quality of life decreased

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Anaemia (lack of blood)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Haemorrhage (bleeding)
  5. Rash
  6. Hypotension (abnormally low blood pressure)
  7. Platelet count decreased
  8. Bradycardia (abnormally slow heart action)
  9. Hyperhidrosis (abnormally increased sweating)
  10. Leukocytosis (increased white blood cells)

What are the existing conditions these people have? *

  1. Anaesthesia: 7 people, 35.00%
  2. Multiple Myeloma (cancer of the plasma cells): 2 people, 10.00%
  3. Stress And Anxiety: 1 person, 5.00%
  4. Sedation: 1 person, 5.00%
  5. Pain: 1 person, 5.00%
  6. Migraine (headache): 1 person, 5.00%
  7. Metastases To Bone (cancer spreads to bone): 1 person, 5.00%
  8. Indigestion: 1 person, 5.00%
  9. Hiv Infection: 1 person, 5.00%
  10. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cefazolin sodium and Levaquin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefazolin sodium and Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefazolin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levaquin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefazolin sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levaquin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on cefazolin sodium and levofloxacin (the active ingredients of Cefazolin sodium and Levaquin, respectively), and Cefazolin sodium and Levaquin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: